PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 26, 2026ChemistrySelect0 citations

Unveiling the Pharmacological Potential of a Pyrazole–Benzodioxole Hybrid Computational Analysis, ADMET Screening, and Molecular Docking Against ABL Tyrosine Kinase

View Full Paper
MYMücahit YılmazHKHanifi Kebiroglu

Key Points

  • The study aims to evaluate the pharmacological potential of a pyrazole–benzodioxole hybrid molecule through computational methods.
  • Conducted integrated in silico analysis using DFT, NCI/RDG, ELF, and molecular docking against ABL tyrosine kinase.
  • Performed multiplatform toxicity prediction and thermochemical evaluations.
  • Investigated interaction properties and molecular conformation stability.
  • Identified moderate binding affinity of the hybrid molecule to ABL tyrosine kinase at −6.588 kcal/mol.
  • Predicted toxicity showed a mixed safety profile, indicating possible mutagenicity and developmental toxicity.
  • Weak noncovalent interactions were crucial in stabilizing the molecular structure.

Abstract

ABSTRACT In this study, the physicochemical, electronic, and interaction properties of a pyrazole–benzodioxole hybrid molecule, 3‐(1,3‐benzodioxol‐5‐yl)‐1 H ‐pyrazole‐5‐carboxylic acid (C 11 H 8 N 2 O 4 ), were systematically investigated using integrated in silico approaches. The novelty of this work lies in combining density functional theory (DFT), noncovalent interaction analysis (NCI/RDG), electron localization function (ELF), thermochemical evaluation, multiplatform toxicity prediction, and molecular docking within a unified computational framework. The results indicate that weak noncovalent interactions play a key role in stabilizing molecular conformation, while thermodynamic behavior is primarily governed by vibrational contributions. Toxicity predictions suggest a mixed safety profile, including potential mutagenicity and developmental toxicity, highlighting important limitations. Molecular docking against ABL tyrosine kinase reveals a moderate binding affinity (−6.588 kcal/mol), which is lower than that typically reported for strong inhibitors, indicating that the compound does not exhibit high inhibitory potency. Overall, the findings suggest that the investigated molecule may serve as a preliminary scaffold for further structural optimization, and its pharmacological relevance requires comprehensive experimental validation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yılmaz et al. (2026) studied this question.

synapsesocial.com/papers/69edabdf4a46254e215b3c28https://doi.org/10.1002/slct.73323
Ask AI
Helpful
Bookmark
Share
View Full Paper